Clinical Trials Directory

Trials / Completed

CompletedNCT04090138

Setria Performance Blend Supplementation

The Effect of Setria Performance Blend on Endurance Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
Male
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

The objective of this trial is to evaluate the effects of setria performance blend supplementation on endurance performance in healthy men.

Detailed description

This study is a randomized, double-blind, placebo-controlled crossover trial in healthy men. Subjects will take either a placebo or setria performance blend (L-citrulline + glutathione) for 8 days. At the day 8, subjects run on the treadmill to measure the time to exhaustion at 90%, 100%, and 110% of peak velocity. Arterial blood flow and blood vessel diameter (via ultrasound), blood analytes (plasma nitrate/nitrite, L-arginine, L-citrulline), subjective feelings of fatigue from a visual analog scale (VAS) and ratings of perceived exertion will be assessed. There is a minimum of a two week washout period in between trials/treatments. The same procedures are completed upon return visit.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSetria performance blendOral capsules
DIETARY_SUPPLEMENTPlaceboOral capsules

Timeline

Start date
2019-11-30
Primary completion
2020-11-01
Completion
2020-11-01
First posted
2019-09-16
Last updated
2021-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04090138. Inclusion in this directory is not an endorsement.